1 May 2023 false No description of principal activity Taxfiler 2024.5 8024128business:PrivateLimitedCompanyLtd2023-05-012024-04-30 80241282023-04-30 80241282023-05-012024-04-30 8024128business:AuditExempt-NoAccountantsReport2023-05-012024-04-30 8024128business:FilletedAccounts2023-05-012024-04-30 80241282024-04-30 8024128business:Director12023-05-012024-04-30 8024128business:RegisteredOffice2023-05-012024-04-30 80241282023-04-30 8024128core:WithinOneYear2024-04-30 8024128core:WithinOneYear2023-04-30 8024128core:ShareCapitalcore:PreviouslyStatedAmount2024-04-30 8024128core:ShareCapitalcore:PreviouslyStatedAmount2023-04-30 8024128core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2024-04-30 8024128core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2023-04-30 8024128core:PreviouslyStatedAmount2024-04-30 8024128core:PreviouslyStatedAmount2023-04-30 8024128business:SmallEntities2023-05-012024-04-30 8024128countries:EnglandWales2023-05-012024-04-30 8024128core:PlantMachinery2023-05-012024-04-30 8024128core:PlantMachinery2023-04-30 8024128core:PlantMachinery2024-04-30 8024128business:OrdinaryShareClass12023-05-012024-04-30 8024128business:OrdinaryShareClass12022-05-012023-04-30 8024128business:Director112023-05-012024-04-30 8024128business:Director112023-04-30 8024128business:Director112024-04-30 80241282022-05-012023-04-30 iso4217:GBP xbrli:shares xbrli:pure
Company Registration No. 8024128 (England and Wales)
Biological Communications Limited Unaudited accounts for the year ended 30 April 2024
Biological Communications Limited Unaudited accounts Contents
Page
- 2 -
Biological Communications Limited Company Information for the year ended 30 April 2024
Director
Mr. Timothy J. Ryder
Company Number
8024128 (England and Wales)
Registered Office
12 Breakspeare 94 College Road Dulwich, London. SE21 7NB
Accountants
Ashley & Co. Chartered Certified Accountants 38 Wey House 15 Church Street Weybridge Surrey KT13 8NA
- 3 -
Biological Communications Limited Statement of financial position as at 30 April 2024
2024 
2023 
Notes
£ 
£ 
Fixed assets
Tangible assets
175 
212 
Current assets
Debtors
28,997 
26,432 
Cash at bank and in hand
122,017 
151,285 
151,014 
177,717 
Creditors: amounts falling due within one year
(15,446)
(19,641)
Net current assets
135,568 
158,076 
Net assets
135,743 
158,288 
Capital and reserves
Called up share capital
1 
1 
Profit and loss account
135,742 
158,287 
Shareholders' funds
135,743 
158,288 
For the year ending 30 April 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 1 September 2024 and were signed on its behalf by
Mr. Timothy J. Ryder Director Company Registration No. 8024128
- 4 -
Biological Communications Limited Notes to the Accounts for the year ended 30 April 2024
1
Statutory information
Biological Communications Limited is a private company, limited by shares, registered in England and Wales, registration number 8024128. The registered office is 12 Breakspeare, 94 College Road, Dulwich, London., SE21 7NB.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
Principal Activity
The activity of the company is that of a medical communications consultancy.
Turnover
Turnover represents the value, net of VAT and discounts, of goods provided to customers and work carried out in respect of services provided to customers.
Tangible fixed assets policy
Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Plant & machinery
Straight Line 15%
4
Tangible fixed assets
Plant & machinery 
£ 
Cost or valuation
At cost 
At 1 May 2023
2,538 
At 30 April 2024
2,538 
Depreciation
At 1 May 2023
2,326 
Charge for the year
37 
At 30 April 2024
2,363 
Net book value
At 30 April 2024
175 
At 30 April 2023
212 
- 5 -
Biological Communications Limited Notes to the Accounts for the year ended 30 April 2024
5
Debtors
2024 
2023 
£ 
£ 
Amounts falling due within one year
VAT
347 
- 
Trade debtors
19,122 
16,524 
Other debtors
9,528 
9,908 
28,997 
26,432 
6
Creditors: amounts falling due within one year
2024 
2023 
£ 
£ 
Taxes and social security
15,446 
19,641 
7
Share capital
2024 
2023 
£ 
£ 
Allotted, called up and fully paid:
1 Ordinary shares of £1 each
1 
1 
8
Loans to directors
Brought Forward 
Advance/ credit 
Repaid 
Carried Forward 
£ 
£ 
£ 
£ 
Mr. Timothy J. Ryder
Amount due by the director to the company
9,908 
9,528 
9,908 
9,528 
9,908 
9,528 
9,908 
9,528 
Please note the amount includes advances on expenses to the director, which are included in 'other debtors'.
9
Average number of employees
During the year the average number of employees was 1 (2023: 1).
- 6 -